Quality by Design Guided Stability‐Indicating HPLC Method for Concurrent Analysis of Clotrimazole and Mometasone Furoate in Cream Formulation
- 20 April 2026
- journal article
- Published by Wiley in Separation Science Plus
- Vol. 9 (4)
Abstract
Clotrimazole (CLOT) is an antifungal and mometasone furoate (MOMF), a corticosteroid used to treat skin infections effectively by killing the pathogenic fungus and reducing inflammation. This work aimed to develop a stability‐indicating liquid chromatographic method for the concurrent quantification of MOMF and CLOT employing a design‐of‐experiment strategy. The elution solvent used to test CLOT and MOMF was a combination of 60:40 v/v acetonitrile and phosphate buffer (pH 4.0). A Shimpack ODS C18 column (4.6 mm × 250 mm, 5 µm) was utilized for this purpose. This approach was tested with a detection wavelength of 249 nm and a flow rate of 1 mL/min. The mobile phase was optimized utilizing a 3 2 full factorial design (quadratic model). The International Conference on Harmonization strategies were used to validate the methodology. The cream formulation comprising both the drugs underwent force degradation study. CLOT was determined to have an acceptable linearity range of 50–600 µg/mL, whereas MOMF had a linearity range of 5–60 µg/mL. The method demonstrated good sensitivity, with detection limit and quantification limit 3.97 and 12.04 µg/mL for CLOT along with 1.14 and 3.45 µg/mL for MOMF. The established methodology was determined to be both accurate (recovery between 98% and 102%) and precise (% RSD < 2). The degradation studies aimed to confirm the efficient separation of CLOT and MOMF from their degradation products. Chromatograms of stressed samples confirmed that degradation products did not interfere with the peaks of the active components.Keywords
This publication has 21 references indexed in Scilit:
- A Stability Indicating HPLC Methodology Applying Quality by Design for the Concurrent Estimation of Luliconazole and Clobetasol Propionate in Cream FormulationSeparation Science Plus, 2025
- Concurrent Analysis of Racecadotril, Ofloxacin, and Ornidazole in a Fixed‐Dose Combination by RP‐HPLC–DAD MethodSeparation Science Plus, 2025
- Quantitative determination of lobeglitazone sulfate and glimepiride in combined tablet by robust high‐performance thin layer chromatographic methodSeparation Science Plus, 2024
- Densitometric simultaneous assessment of teneligliptin hydrobromide and pioglitazone hydrochloride in combined tabletSeparation Science Plus, 2023
- Development and validation of high‐performance thin layer chromatographic method for concurrent estimation of dapagliflozin and vildagliptin in combined tabletSeparation Science Plus, 2023
- Strategies for stabilizing formulation and QbD assisted development of robust stability indicating method of azilsartan medoxomil/chlorthalidoneJournal of Pharmaceutical and Biomedical Analysis, 2020
- Quality by design approach: Regulatory needArabian Journal of Chemistry, 2017
- Forced degradation of mometasone furoate and development of two RP-HPLC methods for its determination with formoterol fumarate or salicylic acidArabian Journal of Chemistry, 2016
- Development of forced degradation and stability indicating studies of drugs—A reviewJournal of Pharmaceutical Analysis, 2014
- Development and validation of HPLC method for determination of clotrimazole and its two degradation products in spray formulationTalanta, 2007